On Aug. 26th, 2024, ZMUni Compliance Centre hosted a webinar titled “Towards Cruelty-Free Cosmetics: Exploring China's Compliance Requirements for New Cosmetic Ingredients of HoSU and Polymers” presented by our Senior Compliance Consultant Lolita Yang and Regulatory Analyst Kimberly Jin.
This webinar focused on the following five key parts:
1.Background: Get Ready for China’s NCI Regulatory Regime
2.China to Accept Animal-alternative Test Data under Specific Conditions
3.Understanding the Application under Situation 3 and 5, NCI with HoSU
4.Understanding the Application under Situation 6, NCI of Polymer
5.Points to Note for NCI Application in China
The following is a highlight of NCI with HoSU presented in this webinar.
| Get Ready for China’s NCI Regulatory Regime
Before diving into the specific requirements for NCI Application, let's first take a look at an overview.
| Understanding the Application Under Situation 3 and 5, NCI with HoSU
In this section, Lolita introduced application for NCI under Situation 3 and Situation 5, NCI with safe use and safe consumption history respectively, mainly including the notification procedure, acceptable alternative animal testing methods, required documentation, and case studies.
In the next article, we will continue to share insights by this webinar focusing on classification of notification scenarios for new cosmetic ingredients in China and highlight key points for Polymer NCI.
Since 2021, ZMUni Compliance Centre has helped dozens of companies complete the notificatons of various NCI. As of the first half of 2024, we assisted nearly ten companies with their notification, accounted for 10% of the total.
ZMUni provides the following service regarding New Cosmetic Ingredients in China, feel free to contact us at info@zmuni.com if you have any questions.
l Registration and filing of new cosmetic ingredients
l Technical amendments for new cosmetic ingredients
l Experimental supervision for ingredient applications
l Application for ingredient submission codes
l Safety assessment reports for ingredients
l Analysis of toxicological data gaps
l Annual monitoring reports and safety risk control report services during the monitoring period
